TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The Global Cosmetics News Week 42 review reported developments in beauty acquisitions, financial performance, retail expansion and manufacturing investment. It also highlighted legal disputes, China customs delays affecting French exporters, and calls for stronger UK aesthetics regulation. Several reported plans and disputes remain subject to further developments.
The week’s corporate news included Galderma agreeing to acquire ZO Skin Health for US$1.5 billion, a move that would expand Galderma’s physician-dispensed skincare portfolio. Bogart sold its Israeli cosmetics retail subsidiary, which operates 47 stores, for €5.8 million. Separately, the European Union approved Kimberly-Clark’s proposed US$40 billion acquisition of Kenvue following a divestment agreement, according to the review. Amazon was also reported to be in discussions to acquire AI start-up Decart for about US$7 billion; that proposed deal is outside the beauty sector.
Financial and commercial updates ranged from luxury beauty to online retail. LVMH reported higher third-quarter sales across its beauty operations and Sephora network. Shein’s UK sales rose 26 percent to £2.58 billion, the review reported, putting the retailer ahead of Asos by sales. e.l.f. Beauty said it planned to direct a US$50 million tariff refund toward pricing and marketing. Executives at Beauty Tech Group sold £6 million in shares after what the report described as strong IPO performance.
Retailers and brands also pursued international growth. CJ Olive Young expanded K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong; Nykaa and L’Oréal supported a new Kiehl’s skincare launch in India; and Kiko Milano outlined plans to double its Indian store footprint by the end of 2026. In the United States, Bluemercury relaunched its makeup label Lune+Aster with a refreshed identity and broader assortment.
Deals and Expansion Reshape Beauty
The developments show how beauty companies are pursuing growth through portfolio deals, new sales channels and local retail expansion, while also managing costs and supply-chain exposure. For consumers, these moves could affect which brands are available, where they are sold and how companies compete on pricing. The review reports corporate plans and results, but does not establish what their longer-term commercial effects will be.
Operational pressures were visible alongside expansion. Estée Lauder invested €5.7 million in advanced manufacturing capabilities at its Belgian facility, while French cosmetics exporters faced customs delays in China amid trade tensions. The combination highlights the importance of production capacity and cross-border access to companies selling across multiple markets.
Products Worth Considering
Therabody TheraFace Mask Glo Cordless LED Skincare Mask
Levoit Vital 100S-P Smart Air Purifier with Washable Pre-Filter
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms up to 1875 ft², Quiet 27 dB Operation, AHAM VERIFIDE Certified, Air Quality Monitor,
As an affiliate, we earn on qualifying purchases.
A Week Across Beauty Markets
The roundup spanned skincare, cosmetics, retail, manufacturing and adjacent technology. It reported digital marketing experiments, including an e.l.f. Cosmetics virtual beauty experience on ZEPETO and an AI-generated concept involving Hunter and Rhode Beauty. The latter prompted questions about unofficial brand collaborations and generative technology; the review did not establish that the concept represented an authorised partnership. Bandai also expanded Tamagotchi licensing into cosmetics in Asian markets.
Other developments included L’Oréal Travel Retail’s sustainability partnership with Avolta, which the report said covers operational practices and consumer engagement. Personnel changes included Bluemercury appointing Stacie Borteck Dattner as Head of Merchandising, ELEMIS co-founder Sean Harrington joining Lempriere Wells as a partner, and Isamaya Ffrench leaving her namesake brand. The roundup also said former Estée Lauder executive John Demsey departed Gap Inc. as the retailer expanded its beauty operations.
Industry standards featured in the week’s reporting as well. Superdrug called for stronger regulation of the UK aesthetics industry, while Kering and LVMH updated a model-protection charter. These initiatives sit alongside the commercial news, reflecting scrutiny of consumer protection and working standards in parts of the sector.
Deals and Disputes Await Detail
The roundup does not provide closing dates or full transaction terms for the Galderma–ZO Skin Health deal, or details of the divestment conditions attached to the EU’s approval of Kimberly-Clark’s Kenvue acquisition. Amazon’s reported discussions with Decart are not described as a completed agreement. The report also gives no further detail on the timing or methodology behind the financial figures, beyond the stated periods and values.
Shiseido’s €2.6 million lawsuit against Shein concerns alleged unauthorised cosmetics sales; the available source does not report a court ruling or Shein’s response. The scope and duration of the China customs delays, and their financial impact on French exporters, are also unspecified. The AI-generated brand concept’s authorisation status and the future of Ffrench’s namesake brand remain unclear in the review.
Next Steps Across the Industry
Follow-up developments will include whether the announced acquisitions proceed to completion, how retailers carry out their stated expansion plans, and whether manufacturing and sustainability investments lead to further operational changes. Kiko Milano’s stated target is to double its Indian retail footprint by the end of 2026; the review does not give a store count or a detailed rollout schedule.
Legal and regulatory developments may also shape the next phase. The outcome of Shiseido’s case, any response from Shein, and further information on customs conditions in China are not included in the report. Superdrug’s call for stronger UK aesthetics regulation and updates to the model-protection charter may prompt additional industry or policy discussion, but no new regulatory decision is reported here.
Key Questions
What was the main development in the Week 42 review?
The review brought together a range of industry updates, led by Galderma’s agreed US$1.5 billion acquisition of ZO Skin Health, alongside retail expansion, financial results, investment and legal and trade pressures.
Did Galderma complete its acquisition of ZO Skin Health?
The source says Galderma agreed to acquire ZO Skin Health. It does not say the transaction has closed or provide a completion date.
What legal dispute involving cosmetics did the report mention?
Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales. The report does not state the court’s decision or include Shein’s response.
Which companies reported retail expansion plans?
The review reported CJ Olive Young distribution through Sephora in Southeast Asia and Hong Kong, a Kiehl’s launch supported by Nykaa and L’Oréal in India, and Kiko Milano’s plan to double its Indian retail footprint by the end of 2026.
What issues remain unresolved?
Deal completion details, the lawsuit’s outcome, the scope and impact of China customs delays, and the future of Isamaya Ffrench’s namesake brand are not settled or fully specified in the source material.
Source: rss
